News: Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

3.90CAD
10 Dec 2009
Price Change (% chg)

$0.34 (+9.55%)
Prev Close
$3.90
Open
--
Day's High
$3.94
Day's Low
$3.53
Volume
260,622
Avg. Vol
355,303
52-wk High
$4.10
52-wk Low
$1.13

view news for:
Select another date:

Tue, Oct 6 2009

CANADA STOCKS-TSX may get boost at open from commodity rally

TORONTO, Oct 6 (Reuters) - Toronto's main stock index could open higher on Tuesday as the resource-heavy index may draw support from the rally in prices for gold and oil.

Continue Reading

UPDATE 1-Theratechnologies posts surprise Q3 profit

Oct 5 (Reuters) - Canadian biotechnology company Theratechnologies Inc reported a surprise quarterly profit, helped by a milestone payment.

UPDATE 1-Theratech shares jump 8 pct on FDA filing

TORONTO, June 1 (Reuters) - Theratechnologies Inc a small Canadian biotechnology company, said on Monday a new drug application with U.S. regulators for a treatment to alleviate a condition inflicting some HIV-infected patients, sending its shares up 8 percent.

CANADA RESEARCH SUMMARY: Jan 14 1926 GMT

Following is a summary of research actions on Canadian companies reported by Reuters on Wednesday. Stock entries are in alphabetical order. For a summary of research on S&P 500 companies, double click on [RCH/US] For a summary of research on non-S&P 500 companies, double click on [RCH/US2] --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION ARC Energy Trust Raymond James Cuts price target to C$20 fr

CANADA RESEARCH SUMMARY: Oct 29 1437 GMT

companies reported by Reuters on Wednesday. Stock entries are

Toronto stocks set for soft open amid profit-taking

TORONTO, June 18 (Reuters) - The Toronto Stock Exchange's main index looked set to take a breather on Wednesday, following three days of strong gains which could prompt investors to book profits.

UPDATE 1-Theratech gets good results in drug trial

TORONTO, June 18 (Reuters) - Theratechnologies Inc said on Wednesday it received positive results in the confirmatory phase 3 trial of its lead compound tesamorelin to treat the increase of central fat accumulation in HIV-infected patients.

Theratechnologies to release more tesamorelin data

TORONTO, April 14 (Reuters) - Theratechnologies said on Monday it would release more results from the Phase 3 trial of tesamorelin by the end of the first half of 2008.

US RESEARCH NEWS-Cantor raises RADVision to buy from hold

Following are the research actions reported by Reuters on Thursday. For actions reported earlier today, please double click on [nBNG283399], [nBNG303600] For a snapshot of research actions, please double click on [SNAP/RCH] --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION RADVision Cantor Raises to buy from hold --------------------------------------------------------------- -------

Toronto stocks seen rising on earnings, Fed eyed

TORONTO, Jan 29 (Reuters) - Toronto's main stock market index was expected to open higher on Tuesday as precious metals prices rocketed to record levels and ahead of another interest rate cut by the U.S. Federal Reserve.

Select another date:

Market Views

» More TH.TO Market Views

Press Releases

view news for: